Objective. Although many efforts have been made to generate small-diameter ( 5 mm) vascular grafts by means of tissue engineering, improvement in patency and functionality still remains a great challenge. It is our hypothesis that to achieve long-term functionality and patency, not only the complete lining with endothelial cells but also full biocompatibility is essential. Design. The aim was the development of a conduit from a scaffold and endothelial progenitor cells (EPC) separated from peripheral blood of a single donor. Materials and methods. EPC and a fibrin preparation were separated from porcine peripheral blood. Fibrin segments were generated seeded with EPC and were perfused in a bioreactor in vitro. Results. From 100 ml blood 12e15 cm long fibrin tubes were successfully generated lined with endothelial-like cells. Seeded tubes showed a remarkable elasticity and burst strength up to 90 mm mercury. Conclusions. Stable fibrin tubes were successfully generated completely lined with an endothelium-like monolayer from fibrin and EPC, both isolated from the same volume of blood. Although their stability is not those needed for arterial grafting, our results raise the hope, that with distinct improvements in future studies functional autologous vascular grafts could be engineered from the patient's own blood.
Introduction
The clinical use of large-calibre synthetic vascular grafts (e.g. Dacron, PTFE) with an internal diameter !5 mm is well established. Other than for largediameter prosthesis increased susceptibility of synthetic materials to platelet deposition, thrombosis, anastomotic neointimal hyperplasia and foreign body reaction in the surrounding tissue accompanied with inferior flow conditions lead to short-or midterm graft failure in small-calibre vascular grafting with an internal diameter 5 mm.
1,2 Autologous vessels, such as the great saphenous vein, provide better long-term results, namely in the femoropopliteal and the coronary artery bypass grafting. 3, 4 But due to atherosclerosis and varicosis up to 30% of patients undergoing bypass grafting do not have suitable autologous vessels. 5, 6 On the other hand the number of vascular surgical operations increases because of advances in vascular surgery accompanied with an increasing prevalence of atherosclerotic arterial disease in an ageing society. 7 In the last decades various attempts have been made, to develop a bioartificial small-calibre vascular prosthesis by means of tissue engineering. 8 The seeding of autologous vascular cells on an adequate scaffold material, which resists the arterial blood pressure and enables vascular cells to attach and spread on it, has thereby become the basic principle. 9 A complete lining of the inner surface of the conduit with functional endothelial cells is needed to achieve its non-thrombogenicity, and some promising results were obtained by lining synthetic small-calibre grafts with endothelial cells. 10, 11 But furthermore, recent studies indicate that also the biocompatibility of the scaffold material plays an important role for the long-term functionality of the conduit.
12e14 Immunological reactions against a not compatible scaffold lead to degeneration of the conduit and deprivation of the functionality culminating in graft failure, whereas a biocompatible conduit on the other hand can be expected not to provoke immunological reactions, but in contrast to underlie the body's own repair mechanisms (remodeling). 15 Therefore, a complete autologous conduit seems to be the best approach to achieve its long-term functionality.
The objective of our efforts is the development of a bioartificial vascular graft by means of an autologous scaffold material seeded with endothelial progenitor cells (EPC). With regard to a later clinical application, the scaffold material should be generated easily without the need for surgical procedure to harvest it from the body of the later recipient. In this study our hypothesis was reviewed whether a bioartificial vascular graft could be generated from proteins and cells of a peripheral blood sample of one single donor.
Methods
Both, cells and fibrinogen were separated from the same volume of peripheral porcine blood. 100 ml blood were drawn under sterile conditions from pigs' internal jugular vein and collected in heparinised syringes (20 units heparin per ml). The blood was centrifuged at 1000 g and 4 C for 20 min. The separated plasma was aspirated gently and stored in a sterile flask at À20 C until its subsequent use.
Generation of the fibrin segments
The fibrin tubes were generated from a fibrinogencomponent, which was separated from the previously frozen plasma and a solution of pooled bovine thrombin and protamine.
Fibrinogen-component
The stored plasma was thawed gently. One tenth was declined, mixed with calcium chloride-solution (40 mM; Baxter, Heidelberg, Germany) at a ratio of 1 to 2.5 and stored separately in a sterile flask. Ethanol (70 vol.%) was added to the remaining plasma up to a concentration of 10% v/v. The solution was stored at 4 C, and 15 min. after addition of ethanol it was centrifuged at 1500 g for 20 min. at 4 C to separate the fibrinogen. The supernatant was decanted and the fibrinogen pellet dissolved gently at 37 C in the priory separated plasma-solution.
Thrombin-component 10 ml of the thrombin-component were mixed from 2000 units protamine (Protamine-HCl, Roche, Grenzach-Wyhlen, Germany), 2000 units aprotinin (Trasylol, Bayer, Leverkusen, Germany), 500 units of pooled bovine thrombin (Baxter) and 5 ml calcium chloride-solution (40 mM; Baxter).
Preparation of the fibrin tubes
Both, the fibrinogen and the thrombin components were given simultaneously in equal volumes in a custom-built casting mould. The mould consisted of two 15 cm long glass tubes, which were closed and fixed at one end (Fig. 1a) . The internal casting cylinder with an outside diameter of 5 mm and the Fig. 1 . The fibrin segments were generated in a custom-built casting mold (a). The mold consisted of two 15 cm long glass tubes, which were closed and fixed at one end. The internal tube had an outside diameter of 5 mm and the inside diameter of the external tube was 11 mm with a 3 mm broad interspace among both tubes, in which the fibrin preparation was filled. Due to shrinkage during the hardening of the fibrin preparation segments with a wall thickness of 1.5e2.5 mm were obtained. Fig. 1b shows a segment of group A after 10 days of incubation in vitro before placing it in the bioreactor.
external cylinder with an inside diameter of 11 mm confined a 3 mm broad space, which was filled with the fibrin preparation. After 15 min. the fibrin tube was removed from the casting mould and given in a culture flask. 50 ml Endothelial Cell Basal Medium 2 (EBM; Clonetics, Cambrex, East Rutherford, NJ, USA) and 50,000 units aprotinin were added.
Isolation and cultivation of EPC
The monocyte fraction was separated by means of density gradient centrifugation in 10 ml of ficollpreparation (Sigma, Hamburg, Germany) and 10 ml of phosphate buffered saline (PBS) (Sigma). After centrifugation at 400 g for 7 min. the buffy coat was aspirated, washed twice in PBS and suspended in 10 ml EBM. The suspension was given into a gelatineprecoated (1% bovine gelatine; Sigma) culture flask. Medium was changed at the following day to remove remaining red blood cells. In the following the medium was changed every second day. On day 7e10 colonies of cells with endothelial-like morphology entered the stage. After reaching confluence the cells were detached with trypsin (Sigma) and placed in a gelatine-precoated 75 cm 2 -culture flask. For seeding procedures only cells were taken from the fourth passage.
Seeding and perfusion
13 tubes were generated and the settings were modified by the incorporation of EPC defining two groups of experimental settings: in the first group (A) cells were incorporated in a density of 0.8e1 Â 10 6 per ml into the fibrin preparation (n ¼ 8), whereas in the second group (B) no cells were incorporated (n ¼ 5). Disposition was done randomly. The segments were incubated in a culture flask for at least 10 days at 37 C and 5 vol.% CO 2 before they were put in the bioreactor system for perfusion process. Medium was changed every second day. Due to poor mechanical properties of the unseeded tubes only the segments of group A were placed in a custom-built bioreactor, which was filled with 50 ml EBM with 20,000 units aprotinin. Perfusion of the segments was performed for 5 days with a roller pump (Masterflex L/S, Ponndorf Gerätetechnik GmbH, Kassel, Germany). Perfusion rate was 120 ml/min. with a mean pressure of 25 mm mercury. Perfusion medium was EBM. Both, perfusion medium and the medium in the reactor were refreshed every second day.
Immunohistochemical characterization of the EPC and the fibrin tubes
The affiliation of the isolated cells to the endothelial cell lineage was proven by immunohistochemical stanings of cytospins from the EPC's populations from the fourth passage and cross-sections of seeded fibrin tubes performed for the presence of the endothelial cell-specific protein von-Willebrand-factor (vWF, monoclonal mouse, clone F8/86, DAKO Cytomation, Hamburg, Germany), the NO-synthase regulating enzyme caveolin-1 (polyclonal mouse, Becton Dickinson Biosciences, clone 2297, Heidelberg, Germany) and vimentin, a protein of the cytoskeleton expressed by cells of mesodermal origin (monoclonal mouse, clone 9V, DAKO). Additionally, staining of cross sections of the fibrin tubes were performed for the presence of the extracellular matrix proteins laminin (polyclonal DAKO) and collagen IV (monoclonal, clone CIV22, DAKO). Staining procedure was performed using the avidin-peroxidase-technique (APT). A goat anti-mouse served as secondary antibody (DAKO). Specimens were viewed under light microscope. Corresponding negative and positive control staining were performed for each antibody.
Scanning electron microscope examination
Specimens of the seeded matrices were fixed by immersion with glutaraldehyde 2.5% in 0.1 mmol/L cacodylate buffer and 2% paraformaldehyde at pH 7.4 for 24 hours. After dehydration in graded series of ethanol solutions, the samples were dried in critical point dryer (E 3000, Polaron). The specimens were coated with platin-palladium (SCD 040, Balzes, Lichtenstein) and examined under scanning electron microscopy (SEM505, Philips/FEI, Eindhoven, Netherlands).
Results

Fibrin tubes
From 100 ml blood approximately 50 ml plasma were separated, and hereof 4e5 ml of the fibrinogen preparation could be separated, which were mixed with an equal volume of the thrombin-component. Therefore, 8e10 ml of the complete fibrin preparation was given into the casting mould (Fig. 1a) . In both groups fibrin tubes with an internal diameter of 5 mm and a length of 12 to 15 cm were obtained (Fig. 1b) . The wall thickness ranged between 1.5e2.5 mm due to shrinkage during the hardening of the fibrin segments. Electron scanning examination revealed the reticular structure of their wall.
Mechanical properties of the fibrin tubes
A: In the first group, the generated tubes were remarkably flexible and elastic and could be stretched up to 150% of their original length, before rupturing (only tested n ¼ 2). Burst strength of up to 90 mm mercury (n ¼ 8, median 82.0 AE 8.7 mm) was measured. B: In the second group, the mechanical properties of the fibrin tubes were found to be distinct inferior from the remarkable properties of the segments of group A. They were found to be more rigid and already disrupted partially during their removal from the mold, so that the burst strength could only be measured in one setting and was less than 20 mm mercury.
Cell isolation and culture
The cells, which were obtained by density gradient centrifugation and cultivated in vitro, were found to be morphologically heterogenic in size and shape during the first week with a low ratio of core-cytoplasm (Fig. 2a) . The majority of the isolated cells died within the first 10 days, whereas during this time in 9 of 14 settings colony-forming cells with an endothelial morphology entered the stage (Fig. 2b) . These colonies reached confluence within 18 days in mean and were expanded. Only cells in the fourth passage were used for seeding procedures, which were found to be positive in immunohistological staining of cytospins for vWf and caveolin-1 (Fig. 2c) . Confluence in the fourth passage was obtained within 30 days after isolation. These findings indicate that late outgrowth endothelial cells (OEC) were obtained at the end of expansion in vitro and were used for seeding experiments.
Immunohistology and electron microscopic findings
Electron microscopic scanning showed a complete coverage of the inner surface with cells with an endothelial-like morphology (Fig. 4) , which were found to be positive for vWf, caveolin-1 and vimentin in immunohistological staining (Fig. 3) . In these segments cells positive for these markers were also found to be spread over the complete wall. By immunohistology neoformation of both matrix proteins laminin and collagen IV was found in a small layer along the layer of endothelial-like cells on the surface. Semiquantitative analysis revealed the expression of Fig. 2 . The cells, which were obtained by density gradient centrifugation and cultivated in vitro, were found to be morphologically heterogenic in size and shape during the first week with a low ratio of core-cytoplasm (a) (Â100). The majority of the isolated cells died within the first 10 days, whereas during this time in 9 of 14 settings colonyforming cells with a typical endothelial morphology entered the stage (b) (Â200). These colonies were grown to confluence within 18 days in mean and expanded in vitro. The cells in the fourth passage were found to be positive in immunohistological stainings of cytospins for von-Willebrandfactor and caveolin-1 (c) (Â200).
laminin to a coherent layer, whereas collagen IV was formed in no coherent pattern.
B: Immunohistochemical staining revealed no formation of collagen IV and laminin and was negative for vWf, caveolin-1 and vimentin.
Discussion
Although in various studies implantable bioartificial small-calibre vascular conduits were generated with good short-or mid-term results in vivo, at present none have reached routine clinical application. 11,16e20 There is strong evidence that the functionality of a vascular conduit depends not only on its lining with functional endothelial cells but also on its other main components: the scaffold and the extracellular matrix. 21 The search for an adequate scaffold is still an ongoing challenge in the field of tissue engineering. Distinct studies indicate that the biocompatibility of the scaffold is essential for long-term functionality and patency of a vascular conduit. 12e14,22,23 A fully biocompatible graft is expected to underlie the recipient body's own repair mechanisms (remodelling), whereas a not compatible would provoke immunological reactions, which could lead to a deterioration of its functionality culminating in graft failure. 13e15,22 Therefore, it seems to be essential to minimize synthetic and allogenic components in a vascular conduit to eliminate immunological reactions. An autologous scaffold must be found, which provides sufficient mechanical properties and enables vascular cells to attach and spread on it.
Beside other proteins fibrin preparations have been found to be an ideal scaffold for 3-dimensional seeding of specific cell types in cardiovascular and other fields of tissue engineering. 20,24e30 The separation of a fibrin preparation from peripheral blood is easy to accomplish, and we could demonstrate here for the first time the generation of stable fibrin tubes from the blood of one single donor. With regard to a later clinical use our method provides an elegant approach due to the low volume of blood, which is needed for their generation and the separation of an adequate amount of progenitor cells for seeding procedures. For the generation of 15 cm long segments with a calibre of 5 mm only 100 ml blood is needed. Only pooled bovine thrombin was used as a potential source of immunological reactions in a later recipient, however, the use of autologous thrombin was described recently. 25 Poor mechanical properties have limited the further application of protein preparations in cardiovascular tissue engineering in the past. Correspondingly, inferior stability and durability were found in our experiments in the not seeded segments of group B. Nevertheless, the mechanical properties of a protein scaffold can be increased by seeding it with vascular cells, which enhance its stability by two main mechanisms: the expression of contractile filaments and the formation of extracellular matrix proteins. In our experiments formation of a nearly coherent layer of laminin was found but only incoherent patterns of collagen IV. These findings have limited significance however, because no quantitative assay was performed. But newly formed extracellular matrix is eligible with regard to higher structural integrity and durability and a superior cellular functionality, which has been shown to depend on cell-matrix interaction. 31 Stability of the seeded fibrin segments have been found to be superior. The burst strength was increased up to 90 mm mercury in the seeded segments compared with only less than 20 in group B, in which no formation of matrix proteins was found. Surprisingly, the mechanical properties were superior already immediately after the generation of the segments (A). At this early point no significant effect from a formation of contractile filaments or matrix proteins can be expected, and the mechanism leading to the enhanced stability at this early time remains unclear.
Coculturing arrangement of smooth muscle cells with endothelial cells has found to be favourable in the past with regard to an increased expression of matrix proteins and enhanced cellular functionality due to cell-cell interaction. 24, 32 For the purpose of arranging such a coculturing setting the expanded progenitor cells were incorporated into the fibrin segments during the casting procedure. Previous studies described the potential of EPC to differentiate into different cell types including mature endothelial cells and smooth muscle cells and their pivotal role in postnatal angiogenesis and vascular regeneration. Due to their properties in the last years EPC have entered the stage of therapeutic application including cardiovascular tissue engineering. 16, 17, 37, 38 EPC were found to circulate in the peripheral blood, from which they can be separated by means of density gradient centrifugation. 39 Recent studies indicate that heterogeneous cell populations with diverse patterns of expression of marker proteins are obtained. Colony forming cells with an endothelial phenotype and the growth pattern, which was found during the expansion of the isolated progenitor cells in our study were previously termed as late outgrowth endothelial cells (OEC). These cells represent only a small subpopulation of the EPC fraction but have found to have a great intrinsic angiogenic capacity and constitute a valuable source for therapeutic and tissue engineering approaches. OEC are described to express endothelial marker proteins as vWf and the NO-synthase regulating protein caveolin-1, which were detected in the cell populations we obtained from peripheral blood, proving that cells from the endothelial lineage were obtained and seeded on the fibrin tubes. 40, 41 The complete lining of the inner surface with endothelial-related cells was achieved. But the incorporated cells inside the wall were still positive for vWF, presuming that there was no or only less differentiation towards a contractile mesenchymal phenotype. The aspired arranging of cocultures of cells with an endothelial and a myocytic phenotype was not obtained accompanied with mechanical properties, which are not sufficient for arterial bypass grafting. This result shows that it is not effectual for obtaining coculture settings to seed only OEC on a fibrin scaffold. To accomplish coculture settings in future experiments the differentiation of the isolated progenitor cells should be influenced towards a myocytic phenotype during expansion by the selective application of growth factors as was found previously for platelet-derived growth factor. 35 In conclusion we developed a simple method for the construction of vascular conduits from the peripheral blood of one single donor. Although the obtained stability of the engineered segments did not reach those, which were needed for the use for arterial bypass grafting, our results raise the hope that with distinct advancements including selective influencing of the differentiation of the separated cells, this method will lead to implantable vascular segments.
